Mindfulness-based Stress Reduction for Multiple Sclerosis

CompletedNot a drug-phase studyRelapsing and progressiveNCT02340754

What it found

Paper found, not read

A paper reports the results; we have not read it yet. See Papers below.

What was tested

Treatment tested

  • Mindfulness-based Stress Reduction

Compared with

  • MS Education Control

What it measured

Main measures

  • Recruitment: Number of participants enrolled over a ten-month period

    Recruitment will be tracked monthly with an expected recruitment period of 10 months..

    Feasibility
  • Adherence to Mindfulness-based Stress Reduction (MBSR): Number of Participants who are present for at least 5 of the classes, including the final class, and complete at least 70% of homework.

    Baseline to 8 weeks

    Quality of life (reported by participants)
  • Adoption: Qualitative assessment of facilitators of and barriers to participation in the MBSR program.

    Week 4 and week 8 of the 8 week intervention.

    Physical function
  • Completion: Number of participants with complete follow-up at 12 months post-intervention.

    14 months

    Feasibility

Other measures (12)

  • Change from baseline in Perceived Stress Scale at 8 weeks

    Baseline and 8 weeks

  • Change in Perceived Stress Scale from 8 weeks to 12 months

    8 weeks and 12 months

  • Change from baseline in Short Form-36 Mental Health Subscale to 8 weeks

    Baseline and 8 weeks

    Quality of life (reported by participants)
  • Change in Short Form-36 Mental Health Subscale from 8 weeks to 12 months

    8 weeks and 12 months

    Quality of life (reported by participants)
  • Change in baseline Patient Reported Outcomes Measurement Information System (PROMIS) Anxiety Score to 8 weeks

    Baseline and 8 weeks

    Mood and sleepQuality of life (reported by participants)
  • Change in PROMIS Anxiety Score from 8 weeks to 12 months

    8 weeks and 12 months

    Mood and sleep
  • Change in baseline PROMIS Depression Score to 8 weeks

    Baseline and 8 weeks

    Mood and sleep
  • Change in PROMIS Depression Score from 8 weeks to 12 months

    8 weeks and 12 months

    Mood and sleep
  • Change in baseline PROMIS Fatigue Score to 8 weeks

    Baseline and 8 weeks

    Fatigue
  • Change in PROMIS Fatigue Score from 8 weeks to 12 months

    8 weeks and 12 months

    Fatigue

Who could take part

Relapsing and progressive · 18 and over

Show the full criteria

Inclusion criteria

* Men and women 18 years of age or older * Definite relapsing remitting, secondary progressive, or primary progressive MS by revised McDonald criteria; * Expanded Disability Severity Scale ≤ 8 at baseline; * Stable on MS disease modifying, anxiolytic, or antidepressant medications for three months prior to baseline visit; * Mild to moderate stress defined by a score of ≥ 10 on the Perceived Stress Scale at screening; * Ability to read and write in English; * Willingness to provide informed consent and comply with study activities, including weekly MBSR sessions and daily practice or weekly Education Control classes.

Exclusion criteria

* MBSR or cognitive behavioral therapy training within the last 5 years; * Current regular meditation or yoga practice (weekly or more often); * MS exacerbation within 30 days of Baseline Visit; * Mini-Mental Status Examination (MMSE) score of ≤ 26 at Screening Visit; * Active suicidal ideation (Beck Depression Inventory) at Screening Visit; * Reported or medically recorded diagnoses of current serious psychological disorders other than depression and anxiety; * Other current life-threatening or severely disabling physical disorders; * Positive pregnancy urine test at Baseline and women planning pregnancy during the study period (contraception not required); * Cancer, other than basal or squamous skin cancers; or * Inability or unwillingness of individual or legal guardian/representative to give written informed consent.

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

The primary purpose of this study is to assess the feasibility of mindfulness-based stress reduction (MBSR) for adults with any type of multiple sclerosis. The secondary objectives are to: 1) Explore the ability of MBSR to improve perceived stress and quality of life compared to an education control group; and 2) Explore the durability of the effects of MBSR over one year.

Papers

Loading reviews and guidelines…

History

    1. Started

      May 2015

    2. Main results due

      May 2017

    3. Finished

      May 2017

    Assembled by software from public sources.